Market Experts Voice Growing Concerns Over Henkel's Strategy

Henkel shares fall 16% as Morgan Stanley downgrades stock, citing margin pressure and weak demand. The firm's acquisition plan is seen as critical to counter challenges.

A significant divergence has emerged between Henkel's corporate ambitions and the market's outlook for the German conglomerate. As the DAX-listed group aggressively pursues an external growth strategy targeting 2026, prominent investment banks are highlighting near-term operational challenges. Mounting costs and tepid consumer demand are placing increasing pressure on the company's performance.

Share Price Reflects Mounting Pressure

The capital markets have reacted sensitively to this complex situation. Over the last 30 trading days, Henkel shares have shed more than 16 percent of their value. Closing at €69.82 on Monday, the stock also fell below its 200-day moving average of €71.62, a technical development that underscores the deteriorating sentiment. The successful execution of planned acquisitions is now viewed as a critical factor to counter negative volume trends and restore investor confidence.

Investment Banks Adopt Cautious Stance

Recent analyst actions reflect a growing skepticism. Morgan Stanley downgraded its rating on the equity from "Equal-weight" to "Underweight." Analyst Tilly Eno pointed to particular risk for the operating margin, citing economic concerns and persistently high raw material costs as likely headwinds for earnings.

Echoing this cautious view, JPMorgan reaffirmed its "Underweight" assessment. The bank's criticism centers on input costs driven by oil prices and the weak volume performance within the consumer goods segment.

In contrast to these operational hurdles, Henkel is emphasizing expansion through targeted acquisitions. Private bank Berenberg views this external growth focus as essential for defending market position in a difficult environment. Planned takeovers in the adhesives and consumer goods sectors are intended to compensate for a lack of organic momentum. Despite acknowledging the strategic relevance of this approach, Berenberg slightly reduced its price target and maintains a "Hold" recommendation.

A summary of the current bank ratings:

• Morgan Stanley: Underweight (downgraded from Equal-weight)
• JPMorgan: Underweight (reaffirmed)
• Berenberg: Hold (price target slightly reduced)

The company's ability to implement its acquisition strategy effectively will be closely watched as the key to reversing the current negative trajectory.